Wildcard: Can 10x Genomics 10x?

<p> In today’s healthcare focused episode, Motley Fool analysts Maria Gallagher and Emily Flippen discuss the prospects for 10x Genomics, a healthcare tech company looking to reform the way researchers discover single cell gene expression. <strong><br /></strong></p> <p><strong>Stocks:</strong> 10x Genomics (NASDAQ: TXG)</p> <p> </p> <p><strong>Check out more of our content here:</strong></p> <p><a href="https://www.fool.com/podcasts/"><span style= "font-weight: 400;">Podcasts</span></a></p> <p><a href= "https://www.youtube.com/user/TheMotleyFool"><span style="font-weight: 400;"> Youtube</span></a></p> <p><a href= "https://twitter.com/mfindustryfocus?lang=en"><span style= "font-weight: 400;">Twitter</span></a></p> <p><span style="font-weight: 400;">Reach us by Email @</span> <a href="http://IndustryFocus@fool.com/"><span style= "font-weight: 400;">IndustryFocus@fool.com</span></a></p>